Descriptor English: | COVID-19 Serotherapy | ||||||
Descriptor Spanish: |
Sueroterapia para COVID-19
| ||||||
Descriptor Portuguese: | Soroterapia para COVID-19 | ||||||
Descriptor French: | Sérothérapie COVID-19 | ||||||
Entry term(s): |
COVID-19 Convalescent Plasma Treatment COVID-19 Convalescent Serum Treatment COVID-19 Hyperimmune Globulin Therapy COVID-19 Serum Therapies COVID-19 Serum Therapy COVID19 Hyperimmune Globulin Therapy COVID19 Serotherapy COVID19 Serum Therapy Convalescent Plasma Treatment for Covid 19 Convalescent Plasma Treatment for Covid-19 Convalescent Serum Treatment for Covid 19 Convalescent Serum Treatment for Covid-19 Coronavirus Disease 19 Serotherapy Coronavirus Disease 2019 Serotherapy Coronavirus Disease-19 Serotherapies Coronavirus Disease-19 Serotherapy Covid 19 Convalescent Sera Treatment Covid-19 Convalescent Sera Treatment Disease-19 Serotherapies, Coronavirus Hyperimmune Globulin Therapy for COVID-19 SARS-CoV-2 Convalescent Plasma Treatment SARS-CoV-2 Convalescent Sera Treatment SARS-CoV-2 Convalescent Serum Treatment Serotherapies, COVID-19 Serotherapies, COVID19 Serotherapies, Coronavirus Disease-19 Serotherapy, COVID-19 Serotherapy, COVID19 Serotherapy, Coronavirus Disease-19 Serum Therapies, COVID-19 Serum Therapies, COVID19 Serum Therapy, COVID-19 Serum Therapy, COVID19 Therapies, COVID-19 Serum Therapies, COVID19 Serum Therapy, COVID-19 Serum Therapy, COVID19 Serum |
||||||
Tree number(s): |
E02.095.465.425.400.330.050.200 E05.478.550.520.050.200 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000093522 | ||||||
Scope note: | Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts. |
||||||
Allowable Qualifiers: |
AE adverse effects CL classification EC economics ES ethics HI history IS instrumentation MO mortality MT methods NU nursing PX psychology SN statistics & numerical data ST standards TD trends VE veterinary |
||||||
Public MeSH Note: | 2023; COVID-19 SEROTHERAPY was indexed under COVID-19 2020-2022, and IMMUNIZATION, PASSIVE 2020-2022 |
||||||
History Note: | 2023 (2020) |
||||||
DeCS ID: | 60180 | ||||||
Unique ID: | D000093522 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2023/01/01 | ||||||
Date of Entry: | 2022/07/14 | ||||||
Revision Date: | 2022/07/14 |
-
-
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Therapeutics [E02]Therapeutics -
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Investigative Techniques [E05]Investigative Techniques
|
COVID-19 Serotherapy
- Preferred
COVID-19 Convalescent Plasma Treatment
- Narrower
COVID-19 Hyperimmune Globulin Therapy
- Narrower
COVID-19 Convalescent Serum Treatment
- Narrower
Concept UI |
M000754225 |
Scope note | Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts. |
Preferred term | COVID-19 Serotherapy |
Entry term(s) |
COVID-19 Serum Therapies COVID-19 Serum Therapy COVID19 Serotherapy COVID19 Serum Therapy Coronavirus Disease 19 Serotherapy Coronavirus Disease 2019 Serotherapy Coronavirus Disease-19 Serotherapies Coronavirus Disease-19 Serotherapy Disease-19 Serotherapies, Coronavirus Serotherapies, COVID-19 Serotherapies, COVID19 Serotherapies, Coronavirus Disease-19 Serotherapy, COVID-19 Serotherapy, COVID19 Serotherapy, Coronavirus Disease-19 Serum Therapies, COVID-19 Serum Therapies, COVID19 Serum Therapy, COVID-19 Serum Therapy, COVID19 Therapies, COVID-19 Serum Therapies, COVID19 Serum Therapy, COVID-19 Serum Therapy, COVID19 Serum |
Concept UI |
M000731265 |
Preferred term | COVID-19 Convalescent Plasma Treatment |
Entry term(s) |
Convalescent Plasma Treatment for Covid 19 Convalescent Plasma Treatment for Covid-19 SARS-CoV-2 Convalescent Plasma Treatment |
Concept UI |
M000731460 |
Preferred term | COVID-19 Hyperimmune Globulin Therapy |
Entry term(s) |
COVID19 Hyperimmune Globulin Therapy Hyperimmune Globulin Therapy for COVID-19 |
Concept UI |
M000731045 |
Preferred term | COVID-19 Convalescent Serum Treatment |
Entry term(s) |
Convalescent Serum Treatment for Covid 19 Convalescent Serum Treatment for Covid-19 Covid 19 Convalescent Sera Treatment Covid-19 Convalescent Sera Treatment SARS-CoV-2 Convalescent Sera Treatment SARS-CoV-2 Convalescent Serum Treatment |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey